top of page
NEWS
VeinTech Announces Opening of U.S. Headquarters in Providence, RI and Provides Company Updates
Perth, Australia-based expanding to U.S. with support of grant from the Rhode Island Life Science Hub
Flagship technology aims to transform IV insertion and improve patient outcomes
Recent clinical data validates the technology in 12 patients and demonstrates a strong potential use in cancer
Flagship technology aims to transform IV insertion and improve patient outcomes
Recent clinical data validates the technology in 12 patients and demonstrates a strong potential use in cancer
VeinTech Secures USD $750,000 Non-Dilutive Grant from Rhode Island Life Science Hub to Launch U.S. Commercialization
Perth, Australia / Providence, Rhode Island — 9th June 2025 – Funding Propels Australia-Born
MedTech Startup into Global Spotlight. VeinTech, a rapidly emerging medtech innovator
revolutionizing IV insertion, has been awarded a USD $750,000 non-dilutive grant by the Rhode
Island Life Science Hub as part of its highly competitive New Business Attraction Program.
MedTech Startup into Global Spotlight. VeinTech, a rapidly emerging medtech innovator
revolutionizing IV insertion, has been awarded a USD $750,000 non-dilutive grant by the Rhode
Island Life Science Hub as part of its highly competitive New Business Attraction Program.
Local company needles US market.
Medical Forum.
28 February 2025.
28 February 2025.
Needle Solution: VeinTech National 7News Feature
7News
22 February 2025
Airing in Sydney, Perth, and Brisbane
22 February 2025
Airing in Sydney, Perth, and Brisbane
bottom of page